IL17A and neoplasm: Therefore, downregulating the expression of IL-17 or blocking its signaling pathway would effectively reduce the emergence of CSCs, inhibit tumorigenesis and tumor cell proliferation, decrease the occurrence of EMT-like changes in CSCs, and inhibit the metastasis and recurrence of tumor cells.